New study tracks Real-World outcomes of Clot-Removing procedures in legs

NCT ID NCT04861506

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 34 times

Summary

This study follows 400 people with acute or subacute blood clots in leg arteries who undergo endovascular treatment (minimally invasive procedures like thrombectomy or catheter-directed thrombolysis). Researchers track how many patients avoid amputation and survive, as well as complications like re-clotting or kidney failure. The goal is to gather real-world data on safety and effectiveness, especially for patients with more severe blockages.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOWER EXTREMITY PROBLEM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fan xin

    RECRUITING

    Hangzhou, Zhejiang, 310006, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could provide evidence to expand endovascular treatment options for patients with acute or subacute leg artery blockages.

What could go wrong

This is an observational study, not a controlled trial, so results may not prove cause and effect. Outcomes depend on surgeon choice and patient factors.

Conditions

The condition(s) this trial relates to.

Thromboembolism thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.